Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

FDA’s new expert panels are rife with financial conflicts and fringe views

FDA panel debated adding a black box warning for SSRIs in pregnancy despite evidence showing benefits outweigh risks for 5-6% of pregnant North American women.

  • As clinicians, the authors have witnessed the maternal mental health crisis in the U.S., where mental illness is the leading cause of maternal deaths.
  • Research shows the benefits of SSRIs for pregnant patients outweigh the risks, and the risks of untreated depression are very serious, including higher risks of preterm birth, low birth weight, and suicide.
  • The FDA-convened panel heavily focused on potential risks of SSRI usage during pregnancy, with some individuals incorrectly asserting these drugs cause autism and birth defects, contradicting research showing they are not associated with such conditions.
Insights by Ground AI
Does this summary seem wrong?

35 Articles

Associated Press NewsAssociated Press News
+32 Reposted by 32 other sources
Lean Left

FDA's new expert panels are rife with financial conflicts and fringe views

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules and promoting fringe views about antidepressants and other products.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 81% of the sources are Center
81% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Live Science broke the news in United States on Sunday, August 17, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal